|
Executive Summary
Injectable Drugs – The Market Opportunity
The Evolving Drug Therapeutics Landscape
Injectable Drug Demand Drivers
Diseases and Indications
Patient Demographics
Developing Economies
Market Factors
Managed Care and Healthcare Costs
Regulations and Regulatory Sentiment
Technology Drivers
Drug Stability
Device Design & Technology
Patient and Care-giver Sentiment
Self-Administration and Patient-friendly Features
Commercial Injection Devices – Evolving Development and
Usage Trends
Syringes
Traditional Disposables
Prefilled Syringes
Glass
Plastic
Prefillable Safety Syringes
Autoinjectors
Safety Syringes
Pen Injectors
Needle-free Injectors
Novel Injection Devices
Injectable Drug Therapeutics – Technology Factors
Formulation Factors
Biological Drug Stability
Sustained Release Formulations
Lyophilization and Reconstitution
Growth of Prefilled Syringes
Partnerships and Alliances
PFS Manufacturing
Fill-and-Finish Operations
Device Selection Factors
Drug-Device Compatibility
Luer vs Fixed Needle
Customized injection Devices
Cost vs Competitive Advantage
Branding/Product Differentiation Opportunities
Injectable Drug Therapeutics – Market Factors
Regulatory Factors and Issues
FDA Regulations
FDA Guidance
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Clinical Trial Factors
Managed Care and Healthcare Economics
Injectable Drug Therapeutics – Segment Assessments and
Forecasts
Anemia
Recent Changes in the Injectables Landscape
Chemotherapy Continue to Drive Demand
Forecasts and
Outlook
Anticoagulants
Lovenox Continues to Dominate Segment
Prefilled Syringes Predominate
Key Demand Drivers and Sustainability
Forecasts and Outlook
Growth Hormone Deficiency
Single-Digit Growth Intensifies Competition
The Impact of New Products
High-end Injection Devices and Product Branding
Forecasts and Outlook
Hepatitis
Limitations of Interferon Therapy
Side Effects and Patient Compliance
Combination Therapies in the Pipeline
Therapeutic Demand Factors
Forecasts and Outlook
Inflammatory Autoimmune Diseases
Growth of TNF Inhibitors Remains Strong
Expanded Indications and Earlier Use
Recent Approvals Cloud Competitive Picture
Numerous Alternative Immune Factors in the Pipeline
Forecasts and Outlook
Osteoporosis
An Unmet Need and a Growing Market
Favorable Demographics Drive Therapeutic Demand
Product Life Cycle Factors and Competing Dosage
Forms
Forecasts and Outlook
Multiple Sclerosis
Biologicals Improve Patient QOL
Copaxone vs the Cytokines
Therapeutic Focus Remains on RRMS
Device Strategies and Self-Administration
Forecasts and Outlook
Reproductive Medicine
Segment Analysis, Product Assessments & Market
Factors
Device Ease-of-Use and Patient Compliance
Therapeutic Demand
Forecasts and Outlook
Vaccines
Prophylactic Vaccines
Prefilled Syringe-to-Vial Ratio Increasing
Extending Childhood Vaccines to Poor Economies
Branded Seasonal Vaccines Increase
Forecasts and Outlook
Therapeutic Vaccines
Near-Term Disease Targets
Long-Term Potential
Forecasts and Outlook
Profiles of Market Participants
|